CN Patent

CN102406626B — 盐酸普拉克索缓释片剂及其制备方法

Assigned to Shenzhen Neptunus Pharmaceutical Co Ltd · Expires 2013-08-28 · 13y expired

What this patent protects

本发明公开了一种盐酸普拉克索缓释片剂的组成配方其及制备方法，所述盐酸普拉克索缓释片剂能够在体内持续稳定地释放，不受胃肠道环境pH变化的影响，每天只需服用一次。所述制备方法简单且适于产业化生产。

USPTO Abstract

本发明公开了一种盐酸普拉克索缓释片剂的组成配方其及制备方法，所述盐酸普拉克索缓释片剂能够在体内持续稳定地释放，不受胃肠道环境pH变化的影响，每天只需服用一次。所述制备方法简单且适于产业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN102406626B
Jurisdiction
CN
Classification
—
Expires
2013-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Neptunus Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.